Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
2
29%
Ph phase_1
4
57%
Ph early_phase_1
1
14%

Phase Distribution

5

Early Stage

0

Mid Stage

0

Late Stage

Phase Distribution7 total trials
Early Phase 1First-in-human
1(14.3%)
Phase 1Safety & dosage
4(57.1%)
N/ANon-phased studies
2(28.6%)

Highest Phase Reached

Phase 1

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Active(1)
Completed(4)
Other(2)

Detailed Status

Completed4
unknown2
Not yet recruiting1

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Early Phase 1

Trials by Phase

Early Phase 11 (14.3%)
Phase 14 (57.1%)
N/A2 (28.6%)

Trials by Status

unknown229%
not_yet_recruiting114%
completed457%

Recent Activity

0 active trials
Showing 5 of 7
not_yet_recruitingnot_applicable

LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma

NCT06888752
unknownearly_phase_1

RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors

NCT05284968
unknownnot_applicable

Use of Autologous Adipose-Derived Stromal Vascular Fraction To Treat Osteoarthritis of Hip, Knee, Ankle, and Thumb Joints

NCT03166410
completedphase_1

Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone

NCT01454336
completedphase_1

Autologous Chondrocyte Intra-articular Implantation in Patients With Severe Hip Osteoarthritis

NCT01500811
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT06888752Not Applicable

LCAR-M61SQ in Treatment of Relapsed/Refractory Multiple Myeloma

Not Yet Recruiting
NCT05284968Early Phase 1

RD07 Cell Injection in the Treatment of Patients With Advanced Claudin18.2 Positive Solid Tumors

Unknown
NCT03166410Not Applicable

Use of Autologous Adipose-Derived Stromal Vascular Fraction To Treat Osteoarthritis of Hip, Knee, Ankle, and Thumb Joints

Unknown
NCT01454336Phase 1

Transplantation of Autologous Mesenchymal Stem Cell in Decompensate Cirrhotic Patients With Pioglitazone

Completed
NCT01500811Phase 1

Autologous Chondrocyte Intra-articular Implantation in Patients With Severe Hip Osteoarthritis

Completed
NCT01206179Phase 1

Treatment of Non Union of Long Bone Fractures by Autologous Mesenchymal Stem Cell

Completed
NCT01207193Phase 1

Treatment Of Bone Cyst With Bone Marrow Mesenchymal Cell Transplantation

Completed

All 7 trials loaded

Drug Details

Intervention Type
BIOLOGICAL
Total Trials
7